EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Impact of extended-spectrum chromosomal AmpC (ESAC) of Escherichia coli on susceptibility to cefiderocol

Otávio Hallal Ferreira Raro iD, Christophe Le Terrier iD, Patrice Nordmann iD, Laurent Poirel iD

Microbiology Spectrum · 02.07.2024 · 12 (7)

DOI: 10.1128/spectrum.00704-24 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Microbiology Spectrum, erschienen am 02.07.2024. Verfasst von Otávio Hallal Ferreira Raro und 3 weiteren Autor:innen. Beteiligte Einrichtung: Medical and Molecular Microbiology, Faculty of Science and Medicine, University of Fribourg, Fribourg, Switzerland. Hauptthemen laut MEDLINE: Escherichia coli, beta-Lactamases, Cephalosporins, Anti-Bacterial Agents. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 27 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: University of Fribourg.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The impact of chromosomally encoded wild-type or extended-spectrum (ESAC) AmpC β-lactamases of Escherichia coli on susceptibility to ceftazidime, cefepime, and cefiderocol was evaluated in different genetic backgrounds, including wild-type, PBP3-modified, and porin-deficient E. coli strains. Recombinant E. coli strains possessing the different backgrounds and producing variable ESACs were evaluated. Although ESAC enzymes conferred resistance to ceftazidime and decreased susceptibility to cefepime as expected, we showed here that cefiderocol was also a substrate of ESAC enzymes. IMPORTANCE We showed here that chromosomally encoded intrinsic extended-spectrum cephalosporinases of Escherichia coli may impact susceptibility not only to ceftazidime and cefepime but also to cefiderocol.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Escherichia colibeta-LactamasesCephalosporinsAnti-Bacterial AgentsMicrobial Sensitivity TestsBacterial ProteinsCefiderocolEscherichia coli ProteinsCeftazidimeChromosomes, BacterialCefepime

Stichwörter der Autor:innen

AmpCESACEscherichia colicefiderocol

Substanzen

beta-LactamasesCephalosporinsAmpC beta-lactamasesAnti-Bacterial AgentsBacterial ProteinsCefiderocolEscherichia coli ProteinsCeftazidimeCefepime

Autor:innen und Institutionen

  • Medical and Molecular Microbiology, Faculty of Science and Medicine, University of Fribourg, Fribourg, Switzerland.
  • Division of Intensive Care Unit, University hospitals of Geneva, Geneva, Switzerland.
  • Swiss National Reference Center for Emerging Antibiotic Resistance (NARA), University of Fribourg, Fribourg, Switzerland.

ORCID-Profile: Otávio Hallal Ferreira Raro, Christophe Le Terrier, Patrice Nordmann, Laurent Poirel

Förderung

  • University of Fribourg

Zitieren

APA

Raro, O. H. F., Le Terrier, C., Nordmann, P., & Poirel, L. (2024). Impact of extended-spectrum chromosomal AmpC (ESAC) of Escherichia coli on susceptibility to cefiderocol. Microbiology Spectrum, 12(7). https://doi.org/10.1128/spectrum.00704-24

Vancouver

Raro OHF, Le Terrier C, Nordmann P, Poirel L. Impact of extended-spectrum chromosomal AmpC (ESAC) of Escherichia coli on susceptibility to cefiderocol. Microbiology Spectrum. 2024;12(7). doi:10.1128/spectrum.00704-24

BibTeX
@article{Raro2024,
  author = {Raro, Otávio Hallal Ferreira and Le Terrier, Christophe and Nordmann, Patrice and Poirel, Laurent},
  title = {Impact of extended-spectrum chromosomal AmpC (ESAC) of Escherichia coli on susceptibility to cefiderocol},
  journal = {Microbiology Spectrum},
  year = {2024},
  volume = {12},
  number = {7},
  doi = {10.1128/spectrum.00704-24}
}
Kostenlos starten →